Lung cancer has been the most common cancer in the world for several decades, accounting for
of all cancer deaths¹
Worldwide, three people die from lung cancer every minute²
This is more per year than breast, colorectal and prostate cancer combined³
of patients are diagnosed with lung cancer at a later stage when their survival chances are lower
Grey: Instances
Red: Survival %
Grey: Instances
Red: Survival %
Grey: Instances
Red: Survival %
During later stages of lung cancer systemic treatments are key. Of these systemic treatments, targeted therapies e.g. monoclonal antibodies have demonstrated survival benefits for patients
References
Cancer Research UK.
WHO.
GLOBOCAN. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. [Accessed December 2016]
Goldstraw et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh)
Edition of the TNM Classification of Malignant Tumours. Journal of Thoracic Oncology 2007; 2: 706_714
National Cancer Institute. SEER Cancer Statistics Review 1975-2013 - Lung cancer. Available at:
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.